168 related articles for article (PubMed ID: 2191814)
21. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
22. Factor IX of the blood coagulation system: a review.
Taran LD
Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
[TBL] [Abstract][Full Text] [Related]
23. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
24. Activity of coagulation and fibrinolytic system components in the vein thrombus.
Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A
Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310
[TBL] [Abstract][Full Text] [Related]
25. Basics of coagulation pathways.
Breen P
Int Anesthesiol Clin; 2004; 42(3):1-9. PubMed ID: 15205636
[No Abstract] [Full Text] [Related]
26. The effects of acute intravascular hemolysis on coagulation and fibrinolysis. 3. Hemoglobinemia casused by ingestion of strong acids.
Riedler G; Straub PW; Frick PG
Helv Med Acta; 1968 Jul; 34(3):223-30. PubMed ID: 5670601
[No Abstract] [Full Text] [Related]
27. [Better understanding of blood coagulation in vivo].
Löwenberg EC; Dielis AW; Meijers JC; ten Cate H; Levi M
Ned Tijdschr Geneeskd; 2009 Jan; 153(1-2):30-7. PubMed ID: 19198210
[No Abstract] [Full Text] [Related]
28. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
[TBL] [Abstract][Full Text] [Related]
29. [Haemocoagulative modifications correlated with pregnancy].
Borrelli AL; De Lucia D; Bernacchi M; Napolitano M; Di Domenico A; Felicetti M; Ferrara C; Meo D; Raffio R; Rivetti A; Sessa M; Tagliaferri A; Torella M
Minerva Ginecol; 2006 Aug; 58(4):315-22. PubMed ID: 16957675
[TBL] [Abstract][Full Text] [Related]
30. Platelet coagulation-protein interactions.
Walsh PN
Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
[TBL] [Abstract][Full Text] [Related]
31. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
[TBL] [Abstract][Full Text] [Related]
33. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
34. Localization of blood coagulation factors in situ in pancreatic carcinoma.
Wojtukiewicz MZ; Rucinska M; Zacharski LR; Kozlowski L; Zimnoch L; Piotrowski Z; Kudryk BJ; Kisiel W
Thromb Haemost; 2001 Dec; 86(6):1416-20. PubMed ID: 11776308
[TBL] [Abstract][Full Text] [Related]
35. Circadian variations in coagulation and fibrinolytic factors among four different strains of mice.
Ohkura N; Oishi K; Sakata T; Kadota K; Kasamatsu M; Fukushima N; Kurata A; Tamai Y; Shirai H; Atsumi G; Ishida N; Matsuda J; Horie S
Chronobiol Int; 2007; 24(4):651-69. PubMed ID: 17701678
[TBL] [Abstract][Full Text] [Related]
36. Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection.
Colucci M; Rossiello MR; Pentimone A; Berloco P; Russo F; Di Leo A; Semeraro N
Thromb Res; 2005; 116(6):471-7. PubMed ID: 16181982
[TBL] [Abstract][Full Text] [Related]
37. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
[TBL] [Abstract][Full Text] [Related]
38. [Blood coagulation and fibrinolysis].
Kienast J; Ostermann H
Z Kardiol; 1993; 82 Suppl 2():65-9. PubMed ID: 8328211
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
Lewis MR; Callas PW; Jenny NS; Tracy RP
Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319
[TBL] [Abstract][Full Text] [Related]
40. [Blood coagulation and fibrinolysis in blood donors after plasmapheresis].
Zukowska B; Kotschy M
Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):120-2. PubMed ID: 1437797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
